The clinical and economic impact of point-of-care CD4 testing in Mozambique and other resource-limited settings: a cost-effectiveness analysis

Journal Article

2014

Permanent link to this Item
http://hdl.handle.net/11427/15273
 http://dx.doi.org/10.1371/journal.pmed.1001725
Files
Hyle_Clinical_Economic_Impact_CD4_2014.pdf (642.36 KB)
Authors
Hyle, Emily P
Jani, Ilesh V
Lehe, Jonathan
Su, Amanda E
Wood, Robin
Quevedo, Jorge
Losina, Elena
Bassett, Ingrid V
Pei, Pamela P
Paltiel, A David
Journal Title

PLOS Medicince

Link to Journal
http://journals.plos.org/plosmedicine
Journal ISSN
Volume Title
Publisher

Public Library of Science

Publisher

University of Cape Town

Department
Desmond Tutu HIV Centre
Faculty
Faculty of Health Sciences
License

http://creativecommons.org/licenses/by/4.0

Series
Abstract
Emily Hyle and colleagues conduct a cost-effectiveness analysis to estimate the clinical and economic impact of point-of-care CD4 testing compared to laboratory-based tests in Mozambique. Please see later in the article for the Editors' Summary
Description
Keywords
HIV diagnosis and management
HIV
Mozambique
Antiretroviral therapy
AIDS
Cost-effectiveness analysis
Life expectancy
HIV epidemiology

Reference:

Hyle, E. P., Jani, I. V., Lehe, J., Su, A. E., Wood, R., Quevedo, J., ... & Walensky, R. P. (2014). The clinical and economic impact of point-of-care CD4 testing in Mozambique and other resource-limited settings: a cost-effectiveness analysis. PLoS medicine, 11(9), e1001725. doi:10.1371/journal.pmed.1001725

Collections
Journal Articles